Related Experiment Video
Updated: Aug 8, 2026

06:13
Solid Plate-based Dietary Restriction in Caenorhabditis elegans
Published on: May 28, 2011
The potential for dietary restriction to increase longevity in humans: extrapolation from monkey studies
Donald K Ingram1, George S Roth, Mark A Lane
1Laboratory of Experimental Gerontology, Intramural Research Program, National Institute on Aging, National Institutes of Health, 5600 Nathan Shock Drive, Baltimore, MD 21224, USA. ingramd@grc.nia.nih.gov
Biogerontology
|May 30, 2006
Summary
Dietary restriction (DR) shows promise for human longevity, but definitive proof remains elusive. Research suggests DR improves health markers and disease risk, though direct lifespan evidence in humans is unlikely.
Area of Science:
- Gerontology
- Nutritional Science
- Biomedical Research
Background:
- Long-term studies on dietary restriction (DR) in rhesus monkeys provide insights into potential human health benefits.
- Extensive research across species indicates that calorie-restricted diets positively impact health and longevity.
- Monkey studies suggest DR improves health markers and reduces disease risk.
Purpose of the Study:
- To evaluate the potential of dietary restriction to increase human longevity based on current scientific evidence.
- To discuss the feasibility of definitively proving DR's effect on human lifespan.
- To redirect focus towards understanding DR mechanisms and developing DR mimetics.
Main Methods:
- Review of long-term rhesus monkey studies on dietary restriction.
- Synthesis of existing literature on the effects of calorie restriction in various species, including humans.
- Analysis of health and disease risk markers associated with DR.
Main Results:
- Lifespan data from monkey studies are currently inconclusive regarding DR's effect on longevity.
- Evidence suggests DR positively influences health and disease risk markers.
- Direct experimental proof of DR increasing human lifespan is unlikely to be obtained.
Conclusions:
- While definitive proof of DR increasing human longevity is improbable, evidence suggests it improves health and disease risk.
- The focus should shift to elucidating DR's fundamental mechanisms and developing pharmacological mimetics.
- Human clinical trials can assess DR mimetics' impact on disease risk, function, and incidence, providing relevant therapeutic insights.
Related Concept Videos
Toxicity Testing in Animals
Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
Development of Human Microbiota
The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
